DIA
Drug Information Association Logo

INNOVATION IN BIOMARKERS AND DISEASE STRATIFICATION

Track:
Innovation in R&D Models

Day & Time:
March 26, 2:00PM - 3:30PM (Central European Standard Time)

Session Number:
1403

Room Number:
Room NO

Type:
Session

Title:
INNOVATION IN BIOMARKERS AND DISEASE STRATIFICATION

Chair(s):
Chris Chamberlain
UCB S.A., Belgium

Description:
Genomic and epigenetic biomarkers offer great promise in refining the development and clinical application of new and existing medicines as well as for assessing disease risk. The use and impact of innovative pharmacogenomic biomarkers in several areas of medicine will be addressed with case studies as well as highlighting the latest advancements in the molecular diagnostics field.

Presentation(s) & Speaker(s):
The Right Patient for the Right Trial: Tools for Enriching Patients and Optimising Trial Design
Diane Stephenson
Associate Director, CAMD
Critical Path Institute, United States

Molecular Taxonomy and Immune-Inflammation - preparing for precision medicine
Chris Chamberlain, MD
Medical Director Personalised Healthcare
Astrazeneca UK Ltd., United Kingdom

The 100,000 Genomes Project and Genomics England
Tim Hubbard
Head of Bioinformatics
King's College, United Kingdom